Abstracts tagged "Osteoarthritis"

Abstract Number: 1108 • 2012 ACR/ARHP Annual Meeting
A Randomized Controlled Trial of Hylan G-F 20 for the Treatment of Carpometacarpal Osteoarthritis
Lisa A. Mandl¹, Scott Wolfe², Aaron Daluiski², Robert N. Hotchkiss³, Stephen L. Lyman⁴ and Jeffrey N. Katz⁵, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Department of Orthopedics, Hospital For Special Surgery, New York, NY, ³Department of Orthopedics, Hospital for Special Surgery, New York, NY, ⁴Research, Hospital Special Surgery, New York, NY, ⁵Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Painful carpometacarpal osteoarthritis (CMC OA) is associated with substantial impairment, and is often unresponsive to medical treatment. Hylan G-F 20 has been shown…
Abstract Number: 255 • 2012 ACR/ARHP Annual Meeting
Clinically Meaningful Effect of Strontium Ranelate On Knee Osteoarthritis Symptoms
O. Bruyere¹, N. Bellamy², J. Brown³, P. Richette⁴, L. Punzi⁵, X. Chevalier⁶, Cyrus Cooper⁷ and Jean-Yves Reginster¹, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²CONROD. The University of Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia, ³Rheumatology Centre,, Quebec City, QC, Canada, ⁴Centre Viggo Petersen / Service de Rhumatologie, Hôpital Lariboisière, Paris, France, ⁵Cattedra e Divisione di Reumatologia, Azienda Ospedaliera di Padova, Padova, Italy, ⁶Service de Rhumatologie, Hôpital Henri-Mondor, Creteil, France, ⁷NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom
Background/Purpose: In the SEKOIA study, strontium ranelate 2g/day has been demonstrated to reduce total WOMAC score, pain subscore and global knee pain assessed using a…
Abstract Number: 2479 • 2012 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Does Not Increase Risk of Short Term Total Knee Replacement (TKR) Adverse Events (AE)
Zachary J. LoVerde¹, Lisa A. Mandl², Beverly K. Johnson², Mark P. Figgie³, Friedrich Boettner⁴ and Susan M. Goodman², ¹New York Medical College, Valhalla, NY, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Orthopedics, Hospital for Special Surgery, New York, NY, ⁴Orthopaedics, Hospital for Special Surgery, New York, NY
Background/Purpose: TKR is commonly performed for rheumatoid arthritis (RA) and osteoarthritis (OA). Historically, RA patients were at higher risk of post-operative AEs. The purpose of…
Abstract Number: 1109 • 2012 ACR/ARHP Annual Meeting
Effects of Strontium Ranelate On Hand Osteoarthritis – Analysis of Data From the Sekoia Trial
E. Maheu¹, C. Cadet² and F. Berenbaum³, ¹AP-HP, Saint-Antoine Hospital, Rheumatology Department and DHU i2B, Paris, France, ²Rheumatology, Paris, France, ³Rheumatology, AP-HP St Antoine Hospital, Paris, France
Background/Purpose: Strontium ranelate (SrRan) has shown the ability to reduce radiological progression of knee osteoarthritis (OA) over 3 years. Patients with knee OA are also…
Abstract Number: 260 • 2012 ACR/ARHP Annual Meeting
Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program
Marc C. Hochberg¹, Steven B. Abramson², David S. Hungerford³, Edward McCarthy⁴, Eric P. Vignon⁵, Michael D. Smith⁶, Leslie Tive⁷, Kenneth M. Verburg⁶ and Christine R. West⁸, ¹Department of Medicine, University of Maryland, Baltimore, MD, ²Dept of Rheumatology/Medicine, NYU Langone Medical Center, New York, NY, ³Department of Ortho Surgery, Johns Hopkins University, Baltimore, MD, ⁴Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, ⁵Rheumatology 2B, Centre Hospitalier, Pierre Benite, France, ⁶Pfizer, Inc., Groton, CT, ⁷Arthritis, Pfizer Inc, New York, NY, ⁸Clinical Sciences, Pfizer, Williamston, MI
Background/Purpose: Tanezumab (TNZ) has been shown to be efficacious for pain and function in patients with hip and knee osteoarthritis (OA). Unexpected reports of adverse…
Abstract Number: 2441 • 2012 ACR/ARHP Annual Meeting
Readability and Suitability Assessment of Patient Education Materials in Rheumatic Diseases
Rennie L. Rhee¹, Joan Marie Von Feldt², H. Ralph Schumacher³ and Peter A. Merkel⁴, ¹Rheumatology, University of Pennsylvania, Philadelphia, PA, ²Rheumatology, Univ of Pennsylvania/Philadelphia VAMC, Philadelphia, PA, ³Department of Medicine, University of Pennsylvania and VA Medical Center, Philadelphia, PA, ⁴University of Pennsylvania, Philadelphia, PA
Background/Purpose: Comprehension of health resources may be challenging for patients particularly those with limited health literacy. The objective of this study was to examine the…
Abstract Number: 1112 • 2012 ACR/ARHP Annual Meeting
Patients with Erosive Osteoarthritis Have Less Extensive Synovitis Than Patients with Rheumatoid Arthritis On Histopathology
Allen P. Anandarajah¹, Stephen Kates², Kate Burns³ and Ellen Giampoli⁴, ¹Dept of Rheumatology, Univ of Rochester Medical Ctr, Rochester, NY, ²Orthopedic Surgery, University of Rochester Medical Center, Rochester, NY, ³Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, ⁴Pathology, University of Rochester Medical Ctr, Rochester, NY
Background/Purpose: Patients with erosive osteoarthritis (EOA) often develop disfiguring deformities and associated decline in hand function. We have previously demonstrated that synovitis was a common…
Abstract Number: 240 • 2012 ACR/ARHP Annual Meeting
Degenerative Changes in Patients with Knee Pain: A Comparative Study Between Ultrasound and Conventional Radiology
Santiago Ruta¹, Erika Catay², Javier Rosa², David A. Navarta³, Ricardo Garcia-Monaco⁴ and Enrique R. Soriano⁵, ¹Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ³Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁴Radiology and Imagenology Department, Hospital italiano de Buenos Aires, Buenos Aires, Argentina, ⁵Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina
Background/Purpose: Knee osteoarthritis (OA) is one of the most common rheumatologic joint diseases and causes an important disability in the elderly population. To date the…
Abstract Number: 2400 • 2012 ACR/ARHP Annual Meeting
Hospital for Special Surgery Osteoarthritis Wellness Initiative: the Impact of a Hospital-Based Exercise Program On Osteoarthritis
Sandra Goldsmith¹, Dana Friedman¹, Linda Roberts¹, Dana Sperber¹ and Laura Robbins², ¹Public and Patient Education, Hospital for Special Surgery, New York, NY, ²Education & Academic Affairs, Hospital for Special Surgery, New York, NY
Background/Purpose: The Centers for Disease Control and Prevention (CDC) reports that about 27 million adults were affected by osteoarthritis (OA) in 2005. OA is characterized…
Abstract Number: 1114 • 2012 ACR/ARHP Annual Meeting
Prevalence of Radiographic and Symptomatic Hip Osteoarthritis in an Urban US Population: The Framingham Osteoarthritis Study
Katherine D. Linsenmeyer¹, Ali Guermazi², Kyu-Chan Kim¹, David T. Felson³, Mary M. Clancy⁴ and Steven C. Vlad⁵, ¹Internal Medicine, Boston Medical Center, Boston, MA, ²Radiology, Boston University, Boston, MA, ³Boston University, Boston, MA, ⁴School of Medicine, Boston University, Boston, MA, ⁵Clinical Epidemiology, Boston University, Boston, MA
Background/Purpose: There are few studies of hip osteoarthritis (OA) in the United States and none in the last 35 years that have addressed the prevalence…
Abstract Number: 241 • 2012 ACR/ARHP Annual Meeting
Excess Body Weight and 4-Year Function Outcomes: Comparison of African-Americans and Caucasians in the Osteoarthritis Initiative
Carmelita J. Colbert¹, Orit Almagor², Joan S. Chmiel², Jing Song³, Dorothy D. Dunlop³, Karen W. Hayes⁴ and Leena Sharma², ¹Department of Medicine, Division of Rheumatology, Northwestern University, Chicago, IL, ²Northwestern University, Chicago, IL, ³Northwestern University Feinberg School of Medicine, Chicago, IL, ⁴Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL
Background/Purpose: Given the heterogeneity of knee OA impact, it is important to identify persons at risk for poor outcome. A better understanding of differences…
Abstract Number: 2043 • 2012 ACR/ARHP Annual Meeting
Documentation of Improvement Over 2 Months in Osteoarthritis, Systemic Lupus Erythematosus, Spondyloarthropathy and Gout Similarly to Rheumatoid Arthritis According to Function, Pain, Patient Global Estimate and RAPID3 On a Multidimensional Health Assessment Questionnaire (MDHAQ)
Isabel Castrejón¹, Martin J. Bergman² and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Taylor Hospital, Ridley Park, PA
Background/Purpose: The health assessment questionnaire (HAQ) and multidimensional HAQ (MDHAQ) were developed initially to assess patients with rheumatoid arthritis (RA). The most feasible method to…
Abstract Number: 1090 • 2012 ACR/ARHP Annual Meeting
A Comparison of Patient-Reported and Measured Range of Motion in a Cohort of Total Knee Replacement Patients
Jamie E. Collins¹, Benjamin N. Rome¹, Vladislav Lerner¹, Jeffrey N. Katz² and Elena Losina¹, ¹Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, ²Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Range of motion (ROM) is an important component of the assessment of total knee replacement (TKR) outcome. Traditionally, ROM is measured by a clinician…
Abstract Number: 245 • 2012 ACR/ARHP Annual Meeting
Similarities of Patient Self-Report Scores From a Multidimensional Health Assessment Questionnaire (MDHAQ), Laboratory Tests, Physician Global Assessment, and Polyarticular Involvement in Patients with Osteoarthritis and Rheumatoid Arthritis
Isabel Castrejón¹, Yusuf Yazici² and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Rheumatology, NYU Hospital for Joint Diseases, New York, NY
Background/Purpose: Rheumatoid arthritis (RA) and osteoarthritis (OA) are distinct diagnoses, based on widely differing pathogenetic mechanisms and treatments. However, OA patients may experience functional disability,…
Abstract Number: 1198 • 2012 ACR/ARHP Annual Meeting
Cardiovascular Risk Factors and Events Are More Frequent Prior to the Onset of Rheumatoid Arthritis Than in the General Population
Helen Pahau Sr.¹, Vibeke Videm², Sanjoy Paul³ and Ranjeny Thomas⁴, ¹Diamantina Institute, University of Queensland Diamantina Institute, Brisbane, Australia, ²Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, and Department of Immunology and Transfusion Medicine, Trondheim University Hospital,, Trondheim, Norway, ³University of Queensland School of Population Health, Brisbane, Australia, ⁴University of Queensland Diamantina Institute, Brisbane, Australia
Background/Purpose: Patients with the inflammatory autoimmune disease Rheumatoid Arthritis (RA) have a higher mortality and morbidity than the general population, predominantly related to cardiovascular disease…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].